Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6136 | 1460 | 29.6 | 67% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1265 | 8379 | CHRONIC LYMPHOCYTIC LEUKEMIA//HAIRY CELL LEUKEMIA//CLL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HAIRY CELL LEUKEMIA | Author keyword | 388 | 70% | 22% | 322 |
2 | HAIRY CELL LEUKAEMIA | Author keyword | 56 | 64% | 4% | 55 |
3 | HAIRY CELL LEUKEMIA VARIANT | Author keyword | 27 | 78% | 1% | 18 |
4 | HAIRY CELLS | Author keyword | 15 | 77% | 1% | 10 |
5 | HAIRY CELL | Author keyword | 11 | 60% | 1% | 12 |
6 | PENTOSTATIN | Author keyword | 10 | 27% | 2% | 33 |
7 | CLADRIBINE | Author keyword | 9 | 15% | 4% | 55 |
8 | DBA44 | Author keyword | 9 | 83% | 0% | 5 |
9 | 2 CDA | Author keyword | 9 | 30% | 2% | 25 |
10 | SEZ EMATOL TR IANTI | Address | 7 | 64% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HAIRY CELL LEUKEMIA | 388 | 70% | 22% | 322 | Search HAIRY+CELL+LEUKEMIA | Search HAIRY+CELL+LEUKEMIA |
2 | HAIRY CELL LEUKAEMIA | 56 | 64% | 4% | 55 | Search HAIRY+CELL+LEUKAEMIA | Search HAIRY+CELL+LEUKAEMIA |
3 | HAIRY CELL LEUKEMIA VARIANT | 27 | 78% | 1% | 18 | Search HAIRY+CELL+LEUKEMIA+VARIANT | Search HAIRY+CELL+LEUKEMIA+VARIANT |
4 | HAIRY CELLS | 15 | 77% | 1% | 10 | Search HAIRY+CELLS | Search HAIRY+CELLS |
5 | HAIRY CELL | 11 | 60% | 1% | 12 | Search HAIRY+CELL | Search HAIRY+CELL |
6 | PENTOSTATIN | 10 | 27% | 2% | 33 | Search PENTOSTATIN | Search PENTOSTATIN |
7 | CLADRIBINE | 9 | 15% | 4% | 55 | Search CLADRIBINE | Search CLADRIBINE |
8 | DBA44 | 9 | 83% | 0% | 5 | Search DBA44 | Search DBA44 |
9 | 2 CDA | 9 | 30% | 2% | 25 | Search 2+CDA | Search 2+CDA |
10 | 2 CHLORODEOXYADENOSINE | 5 | 17% | 2% | 28 | Search 2+CHLORODEOXYADENOSINE | Search 2+CHLORODEOXYADENOSINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PENTOSTATIN | 71 | 50% | 7% | 101 |
2 | 2 CHLORODEOXYADENOSINE | 37 | 25% | 9% | 127 |
3 | RETICULOENDOTHELIOSIS | 33 | 52% | 3% | 44 |
4 | CLADRIBINE | 28 | 29% | 6% | 83 |
5 | PENTOSTATIN 2 DEOXYCOFORMYCIN | 25 | 75% | 1% | 18 |
6 | NORTHWESTERN UNIVERSITY EXPERIENCE | 24 | 91% | 1% | 10 |
7 | REMISSIONS | 22 | 37% | 3% | 49 |
8 | 2 CHLORODEOXYADENOSINE 2 CDA | 21 | 71% | 1% | 17 |
9 | 2 DEOXYCOFORMYCIN | 13 | 28% | 3% | 40 |
10 | LOW DOSE VEMURAFENIB | 12 | 75% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
How I treat hairy cell leukemia | 2010 | 51 | 61 | 89% |
Hairy cell leukemia: short review, today's recommendations and outlook | 2014 | 6 | 82 | 80% |
Current treatment options in hairy cell leukemia and hairy cell leukemia variant | 2006 | 27 | 99 | 87% |
Hairy cell leukemia: Current concepts | 2008 | 12 | 57 | 77% |
Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment | 2011 | 22 | 59 | 81% |
Advances in the treatment of hairy-cell leukaemia | 2003 | 36 | 72 | 90% |
Modern Strategies for Hairy Cell Leukemia | 2011 | 9 | 67 | 90% |
Hairy cell leukemia: Update on molecular profiling and therapeutic advances | 2014 | 1 | 58 | 84% |
TREATMENT OF HAIRY-CELL LEUKEMIA | 1992 | 61 | 59 | 73% |
Treatment of hairy-cell leukemia: Current views | 1999 | 33 | 89 | 84% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SEZ EMATOL TR IANTI | 7 | 64% | 0.5% | 7 |
2 | AOUS | 6 | 47% | 0.6% | 9 |
3 | IDA M CECIL H GREEN CANC | 3 | 35% | 0.4% | 6 |
4 | J DALLAS CLARK CHAIR CLIN CANC | 2 | 67% | 0.1% | 2 |
5 | HEMATOL CLIN ONCOL SERAGNOLI | 1 | 50% | 0.1% | 2 |
6 | CLIN IMMUNOTHER Y SECT | 1 | 29% | 0.3% | 4 |
7 | DIPARTIMENTO MED CLIN SCI IMMUNOL | 1 | 13% | 0.5% | 8 |
8 | LYMPHOMA LEUKEMIA UNIT | 1 | 21% | 0.2% | 3 |
9 | ABT TRANSLAT ONKOL | 1 | 50% | 0.1% | 1 |
10 | CANC EPIDEMIOL HLTH SERV | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000157242 | SPLENIC MARGINAL ZONE LYMPHOMA//NODAL MARGINAL ZONE LYMPHOMA//MONOCYTOID B CELL LYMPHOMA |
2 | 0.0000117865 | T LYMPHOCYTE IMMUNOLOGY//CLIN HOSP O NOVOSEL MED MED//MITOGEN INDUCED CELLULAR CYTOTOXICITY |
3 | 0.0000102225 | FLUDARABINE//CHRONIC LYMPHOCYTIC LEUKEMIA//CLADRIBINE |
4 | 0.0000099873 | TUBULORETICULAR STRUCTURES//TUBULORETICULAR INCLUSIONS//RIBOSOME LAMELLA COMPLEXES |
5 | 0.0000070971 | T CELL PROLYMPHOCYTIC LEUKEMIA//T PLL//TCL1 |
6 | 0.0000054520 | PARANEOPLASTIC VASCULITIS//PALMAR FASCIITIS//LEUKEMIC ARTHRITIS |
7 | 0.0000047373 | T CELL ASSOCIATED ANTIGENS//CD8 ANTIGEN//B CELL NON HODGKIN LYMPHOMA B NHL |
8 | 0.0000046622 | SOLUBLE INTERLEUKIN 2 RECEPTOR//SOLUBLE INTERLEUKIN 2 RECEPTOR SIL 2R//SOLUBLE INTERLEUKIN 2 RECEPTOR SIL2R |
9 | 0.0000044016 | CHRONIC LYMPHOCYTIC LEUKEMIA//CLL//B CLL |
10 | 0.0000043762 | ANTI CYTOKINE VACCINATION//ANTI IFN ALPHA IMMUNIZATION//INTERFERON ANTIBODIES |